Page last updated: 2024-10-29

ketamine and Cerebral Arterial Diseases

ketamine has been researched along with Cerebral Arterial Diseases in 1 studies

Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.

Cerebral Arterial Diseases: Pathological conditions of intracranial ARTERIES supplying the CEREBRUM. These diseases often are due to abnormalities or pathological processes in the ANTERIOR CEREBRAL ARTERY; MIDDLE CEREBRAL ARTERY; and POSTERIOR CEREBRAL ARTERY.

Research Excerpts

ExcerptRelevanceReference
"Ketamine was administered as a 50 mg/kg i."1.28Effects of ketamine on outcome from temporary middle cerebral artery occlusion in the spontaneously hypertensive rat. ( Baker, MT; Ridenour, TR; Todd, MM; Warner, DS, 1991)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ridenour, TR1
Warner, DS1
Todd, MM1
Baker, MT1

Other Studies

1 other study available for ketamine and Cerebral Arterial Diseases

ArticleYear
Effects of ketamine on outcome from temporary middle cerebral artery occlusion in the spontaneously hypertensive rat.
    Brain research, 1991, Nov-22, Volume: 565, Issue:1

    Topics: Animals; Arterial Occlusive Diseases; Blood Pressure; Cerebral Arterial Diseases; Cerebral Arteries;

1991